CN104940889B - Traditional Chinese medicine preparation for patients with internal medicine neurosis - Google Patents

Traditional Chinese medicine preparation for patients with internal medicine neurosis Download PDF

Info

Publication number
CN104940889B
CN104940889B CN201510447845.XA CN201510447845A CN104940889B CN 104940889 B CN104940889 B CN 104940889B CN 201510447845 A CN201510447845 A CN 201510447845A CN 104940889 B CN104940889 B CN 104940889B
Authority
CN
China
Prior art keywords
parts
neurosis
patients
chinese medicine
ginseng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510447845.XA
Other languages
Chinese (zh)
Other versions
CN104940889A (en
Inventor
曹菁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Dekang Pharmaceutical Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510447845.XA priority Critical patent/CN104940889B/en
Publication of CN104940889A publication Critical patent/CN104940889A/en
Application granted granted Critical
Publication of CN104940889B publication Critical patent/CN104940889B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation for patients with medical neurosis, which is prepared from the following raw materials in parts by weight: 7-15 parts of vinegar tortoise plastron, 3-10 parts of ginseng, 25-30 parts of arillus longan, 7-9 parts of fried jujube kernel, 16-25 parts of rhizoma acori graminei, 15-25 parts of polygala tenuifolia, 3-5 parts of akebia stem, 7-15 parts of rush, 1-2 parts of raw liquorice, 3-5 parts of fructus cannabis, 25-35 parts of poria cocos, 8-15 parts of ginger, 5-9 parts of coptis chinensis, 7-13 parts of concha haliotidis and 5-9 parts of vine of multiflower knotweed. The Chinese medicinal preparation has the advantages of good treatment effect, high reliability, wide adaptability and no toxic or side effect on patients with the internal neurosis.

Description

A kind of Chinese medicine preparation for internal medicine Patients with Neurosis
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to a kind of Chinese medicine preparation for internal medicine Patients with Neurosis.
Background technology
Neurosis refers to one kind based on phrenoblabia caused by many factors such as society, environment, psychology, physiology Disease.It is mainly shown as the decline of cerebration ability, worry, anxiety, anxiety, depression, terror, obsessive symptoms, depressive symptom, divides From symptom, conversion symptom or various Somatic discomfort senses.Belong to the diseases scopes such as traditional Chinese medicine melancholia, demented, insomnia, hysteria.In recent years Morbidity increases year by year, and since the etiology and pathogenesis of the disease is complicated, extent of disease is wider, and clinical manifestation is changeable, more than Western medicine side effect and Unsatisfactory curative effect brings certain difficulty to clinical diagnosis and treatment.Neurosis is the illness of the more difficult pool of Neurology, at present both at home and abroad Generally use control method be using calm and medicine against depressive disorders, take these drugs not only the state of an illness be difficult to control curative effect compared with Difference, and toxic side effect and some adverse reactions are will produce, new body and mind sufferings are caused to patient.
Chinese patent CN103599398A disclose it is a kind for the treatment of the Chinese medicine preparation of neurosis, and specifically disclose using from The following heavy part composition of drug:4-12 grams of rhizoma anemarrhenae, 7-13 grams of Radix Polygalae, 3-10 grams of Rhizoma Gastrodiae, 14-23 grams of arillus longan, Polygonum multiflower knotweed 25-32 Gram, 9-15 grams of jujube kernel, 3-6 grams of kuh-seng, 3-5 grams of the coptis, 2-10 grams of root of Aucklandia lappa Decne, 3-6 grams of the fruit of Chinese wolfberry, 1-5 grams of Chinese cassia tree, rhizoma atractylodis macrocephalae 5-15 Gram, it is processed by above-mentioned Chinese medicine and weight.
A kind of Chinese medicine preparations for treating neurosis of Chinese patent CN1562105A, it is characterised in that by following drug weight part Composition:8~12 grams of rhizoma anemarrhenae, 7~13 grams of Radix Polygalae, 6~10 grams of Rhizoma Gastrodiae, 28~35 grams of arillus longan, 25~32 grams of Polygonum multiflower knotweed, jujube kernel 9 ~15 grams, 6~12 grams of kuh-seng, 6~10 grams of the coptis, 0~10 gram of root of Aucklandia lappa Decne, 6~12 grams of the fruit of Chinese wolfberry, 0~10 gram of Chinese cassia tree, Rhizoma Atractylodis Macrocephalae 10~ 15 grams, 8~15 grams of Fructus Corni, 0~10 gram of radix rehmanniae preparata.
A kind of Chinese medicine preparations for treating neurosis of Chinese patent CN102225186A, the drug that the present invention treats neurosis are Medicament made of the raw material matched following weight parts:20-40 parts of vinegar tortoiseshell, 3-10 parts of ginseng, 10-20 parts of arillus longan, lily 8-12 parts of 15-25 parts, 15-25 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 8-12 parts of grass-leaved sweetflag, 10-20 parts of Radix Polygalae and Radix Curcumae.
But the Chinese medicine preparation generally existing therapeutic effect of existing treatment internal medicine neurosis is poor, reliability is low, adapts to The problems such as property is poor.
Invention content
The above problem existing for Chinese medicine preparation for existing treatment internal medicine neurosis, the object of the present invention is to provide one kind Therapeutic effect is preferable, and reliability is higher, and adaptability is wider, and the pure Chinese medicinal preparation for the treatment nerve having no toxic side effect.
The technical scheme is that the drug that the present invention treats internal medicine neurosis is the raw material matched by following weight parts Manufactured medicament:
7-15 parts of vinegar tortoiseshell, 3-10 parts of ginseng, 25-30 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 16-25 parts of grass-leaved sweetflag, Radix Polygalae 15-25 parts, 3-5 parts of akebi, 7-15 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, 25-35 parts of Poria cocos, ginger 8-15 5-9 parts part, 5-9 parts of the coptis, 7-13 parts of the shell of seaear of fleece-flower root rattan.
Above-mentioned each component preferred content be 8-12 parts of vinegar tortoiseshell, 5-9 parts of ginseng, 25-28 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 20-23 parts of grass-leaved sweetflag, 20-25 parts of Radix Polygalae, 3-5 parts of akebi, 10-12 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, Fu 5-7 parts 30-35 parts of Siberian cocklebur, 10-15 parts of ginger, 5-7 parts of the coptis, 9-11 parts of the shell of seaear of fleece-flower root rattan.
Above-mentioned each component preferred content be 9-10 parts of vinegar tortoiseshell, 7-9 parts of ginseng, 26-28 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 20-23 parts of grass-leaved sweetflag, 23-25 parts of Radix Polygalae, 3-5 parts of akebi, 10-12 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, Fu 5-7 parts 30-35 parts of Siberian cocklebur, 10-15 parts of ginger, 5-7 parts of the coptis, 9-11 parts of the shell of seaear of fleece-flower root rattan.
Above-mentioned each component preferred content is 9 parts of vinegar tortoiseshell, 8 parts of ginseng, 27 parts of arillus longan, 8 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, grass-leaved sweetflag 23 Part, 23 parts of Radix Polygalae, 3 parts of akebi, 10 parts of rush, 1 part of licorice, 5 parts of fructus cannabis, 33 parts of Poria cocos, 13 parts of ginger, 6 parts of the coptis, 11 parts of the shell of seaear, 7 parts of fleece-flower root rattan.
The preparations such as graininess can be made in the Chinese medicine preparation for the treatment of internal medicine neurosis provided by the present invention, and preparation method is adopted With existing conventional method.
The present invention is improved innovation on the basis of Chinese patent CN102225186A, by the arduous examination of scientific research personnel It testing, we finally found that the Chinese medicine preparation for the treatment of internal medicine neurosis provided by the present invention, and that there are therapeutic effects is good, and reliability is high, Cure rate is high, and remarkable advantages are extensively waited using crowd.
Specific implementation mode
Embodiment 1
7 parts of vinegar tortoiseshell, 3 parts of ginseng, 25 parts of arillus longan, 7 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 16 parts of grass-leaved sweetflag, 15 parts of Radix Polygalae, 3 parts of akebi, lamp 7 parts of heart grass, 1 part of licorice, 3 parts of fructus cannabis, 25 parts of Poria cocos, 8 parts of ginger, 5 parts of the coptis, 7 parts of the shell of seaear, 5 parts of fleece-flower root rattan.
Embodiment 2
15 parts of vinegar tortoiseshell, 10 parts of ginseng, 30 parts of arillus longan, 9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 25 parts of grass-leaved sweetflag, 25 parts of Radix Polygalae, 5 parts of akebi, 13 parts of 15 parts of rush, 2 parts of licorice, 5 parts of fructus cannabis, 35 parts of Poria cocos, 15 parts of ginger, 9 parts of the coptis, shell of seaear fleece-flower root rattans 9 Part.
Embodiment 3
10 parts of vinegar tortoiseshell, 5 parts of ginseng, 27 parts of arillus longan, 8 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 20 parts of grass-leaved sweetflag, 20 parts of Radix Polygalae, 4 parts of akebi, 10 parts of 10 parts of rush, 1 part of licorice, 3 parts of fructus cannabis, 30 parts of Poria cocos, 10 parts of ginger, 6 parts of the coptis, shell of seaear fleece-flower root rattans 8 Part.
Embodiment 4
9 parts of vinegar tortoiseshell, 8 parts of ginseng, 27 parts of arillus longan, 8 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 23 parts of grass-leaved sweetflag, 23 parts of Radix Polygalae, 3 parts of akebi, lamp 10 parts of heart grass, 1 part of licorice, 5 parts of fructus cannabis, 33 parts of Poria cocos, 13 parts of ginger, 6 parts of the coptis, 11 parts of the shell of seaear, 7 parts of fleece-flower root rattan.
Comparative example 1
In addition to not having the vine of multiflower knotweed, remaining is the same as embodiment 1.
Comparative example 2
In addition to not having the shell of seaear, remaining is the same as embodiment 1.
Comparative example 3
In addition to not having fructus cannabis, remaining is the same as embodiment 1.
Comparative example 4
In addition to not having grass-leaved sweetflag, remaining is the same as embodiment 1.
Comparative example 5
In addition to shell of seaear content is 6 parts, remaining is the same as embodiment 1.
Comparative example 6
In addition to shell of seaear content is 14 parts, remaining is the same as embodiment 1.
One, case selection standard
(1) diagnostic techniques
1, Western medicine diagnostic criteria
(1) symptom standard, it is 1 at least following:1. frightened;2. forcing;3. panic attack;4. anxiety;5. body shape or Symptom;6. somzatization disease;7. hypochondriasis symptom;8. neurasthenia symptom.
(2) disease journey standard meets symptom standard at least three moon.
(3) serious standard, the impaired mental disease amount of social function, promotes its active to seek medical advice.
2, tcm diagnosis standard
(1) symptom standard:Easily probably have palpitation, irritable emotion, feel restless, insomnia and dreamful sleep, depressed emotion, suspicious worry too much, is smart Refreshing nervous, kind sigh, distending pain in the chest and hypochondrium, spiritlessness and weakness, headache and dizzy, burnout are mostly sleeping, forgetful indifferent.
(2) differential diagnosis in tcm standard
1. the insufficiency of heart and spleen:Insomnia and dreamful sleep, lustreless complexion, lassitude hypodynamia, loss of appetite, dizzy forgetful, lassitude, pale tongue Tongue is white, and arteries and veins is thin and delicate.
2. the heart and gallbladder deficiency of vital energy:Palpitaition is timid, susceptible to fright and fear, suspicious kind worry, absent-minded, irritable emotion, pale tongue with white fur, arteries and veins is thin It is weak;
3. fire excess from yin deficiency:Anxious, restlessness of asrhenia type and insomnia, the tired forgetful, dizziness and tinnitus of god, dysphoria in chestpalms-soles, soreness and weakness of waist and knees, tongue are red It is few
Tongue, thready rapid pulse;
4. mental disorder pent-up mental depression, mind are dull-witted, giddy bored, automatic speaking, greasy fur on tongue, wiry and rolling pulse.
(2) case standard is tested
1, it is included in case standard
(1) doctor trained in Western medicine diagnosis meets:Meet fear, anxiety, neurasthenia diagnostic symptom 3 months or more;
(2) tcm diagnosis meets:Tcm diagnosis meets the insufficiency of heart and spleen, the heart and gallbladder deficiency of vital energy, fire excess from yin deficiency or mental disorder pent-up person.2、 Excluded cases standard
Exclude organic mental disorders;Psychoactive drug substance and non-addictive substance caused by mental disorder;Various psychotic diseases Obstacle, such as schizophrenia, paranoid disorder, mood disorder etc..
Two, therapy
Random grouping own control comparison method is taken, the pretherapy and post-treatment symptom of patient, sign and results change are compared.
1, treatment group every group 50 take treatment neurological disease Gilles de la Tourette's syndrome and drug prepared by embodiment 1-4,6 tablets each time, 3 times a day.
2, control group every group 50 take treatment neurological disease Gilles de la Tourette's syndrome and drug and Western medicine prepared by comparative example 1-6 Common drug, 6 tablets each time, 3 times a day.
Three, parameters for observation on effect
1, the mood, mind of patient, language, behavior, the functions such as sleep;
2, tcm symptom, tongue picture, pulse condition.
Four, curative effect judging standard
1, it is almost recovered:Symptom after taking medicine disappears, and 2 years again without repeatedly;
2, effective:Medication control, 1 year or more again without repeatedly;
3, effectively:Symptom is reduced, and is mitigated;
4, invalid:Symptom is without substantially changeing.
Five, treatment results
Table 1
By embodiment 1-4 it can be seen from the data in table 1 comparative example 1- is substantially better than in terms of the effect for the treatment of neurosis 6 and Western medicine group therapeutic effect, in conjunction with the embodiments 1-4 and comparative example 1-6 and table 1 can obtain, each component content and group Final therapeutic effect is had a significant impact at the adjustment of ingredient.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, any made by repair Change, equivalent replacement, improvement etc., be all included in the scope of protection of the present invention.

Claims (4)

1. a kind of Chinese medicine preparation for internal medicine Patients with Neurosis, which is characterized in that the raw material matched by following weight parts forms: 7-15 parts of vinegar tortoiseshell, 3-10 parts of ginseng, 25-30 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 16-25 parts of grass-leaved sweetflag, 15-25 parts of Radix Polygalae, 3-5 parts of akebi, 7-15 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, 25-35 parts of Poria cocos, 8-15 parts of ginger, coptis 5-9 5-9 parts part, 7-13 parts of the shell of seaear of fleece-flower root rattan.
2. the Chinese medicine preparation according to claim 1 for internal medicine Patients with Neurosis, which is characterized in that by following weight parts The raw material of proportioning forms:8-12 parts of vinegar tortoiseshell, 5-9 parts of ginseng, 25-28 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, grass-leaved sweetflag 20-23 Part, 20-25 parts of Radix Polygalae, 3-5 parts of akebi, 10-12 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, 30-35 parts of Poria cocos, life 5-7 parts 10-15 parts of ginger, 5-7 parts of the coptis, 9-11 parts of the shell of seaear of fleece-flower root rattan.
3. the Chinese medicine preparation according to claim 2 for internal medicine Patients with Neurosis, which is characterized in that by following weight parts The raw material of proportioning forms:9-10 parts of vinegar tortoiseshell, 7-9 parts of ginseng, 26-28 parts of arillus longan, 7-9 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, grass-leaved sweetflag 20-23 Part, 23-25 parts of Radix Polygalae, 3-5 parts of akebi, 10-12 parts of rush, 1-2 parts of licorice, 3-5 parts of fructus cannabis, 30-35 parts of Poria cocos, life 5-7 parts 10-15 parts of ginger, 5-7 parts of the coptis, 9-11 parts of the shell of seaear of fleece-flower root rattan.
4. the Chinese medicine preparation for internal medicine Patients with Neurosis according to one of claim 1-3, which is characterized in that by The raw material composition of following weight parts proportioning:It is 9 parts of vinegar tortoiseshell, 8 parts of ginseng, 27 parts of arillus longan, 8 parts of stir-baked SEMEN ZIZIPHI SPINOSAE, 23 parts of grass-leaved sweetflag, remote 23 parts of will, 3 parts of akebi, 10 parts of rush, 1 part of licorice, 5 parts of fructus cannabis, 33 parts of Poria cocos, 13 parts of ginger, 6 parts of the coptis, Shi Jue Bright 7 parts of 11 parts of fleece-flower root rattans.
CN201510447845.XA 2015-07-27 2015-07-27 Traditional Chinese medicine preparation for patients with internal medicine neurosis Active CN104940889B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510447845.XA CN104940889B (en) 2015-07-27 2015-07-27 Traditional Chinese medicine preparation for patients with internal medicine neurosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510447845.XA CN104940889B (en) 2015-07-27 2015-07-27 Traditional Chinese medicine preparation for patients with internal medicine neurosis

Publications (2)

Publication Number Publication Date
CN104940889A CN104940889A (en) 2015-09-30
CN104940889B true CN104940889B (en) 2018-08-07

Family

ID=54156312

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510447845.XA Active CN104940889B (en) 2015-07-27 2015-07-27 Traditional Chinese medicine preparation for patients with internal medicine neurosis

Country Status (1)

Country Link
CN (1) CN104940889B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194049A (en) * 2015-11-05 2015-12-30 王永红 Traditional Chinese medicine for treating patient suffering from internal medicine neurosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225186A (en) * 2011-06-27 2011-10-26 史建钢 Medicine for treating neurosis and preparation method thereof
CN104324347A (en) * 2014-11-13 2015-02-04 山东中大药业有限公司 Traditional Chinese medicine composition for treating insomnia caused by insufficiency of heart and spleen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225186A (en) * 2011-06-27 2011-10-26 史建钢 Medicine for treating neurosis and preparation method thereof
CN104324347A (en) * 2014-11-13 2015-02-04 山东中大药业有限公司 Traditional Chinese medicine composition for treating insomnia caused by insufficiency of heart and spleen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中西医结合治疗广泛性焦虑症临床研究;王任昌等;《实用中医药杂志》;20130731;第29卷(第7期);563-564 *
归脾汤治疗心脾两虚型郁病30例;李光英;《中国中医药现代远程教育》;20131031;第11卷(第19期);35-36 *

Also Published As

Publication number Publication date
CN104940889A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
CN105327287A (en) Pharmaceutical composition for treating psychosis and preparation technology thereof
CN105194316A (en) Medicinal liquor with functions of tonifying kidney, strengthening Yang and boosting immunity
CN104940889B (en) Traditional Chinese medicine preparation for patients with internal medicine neurosis
CN104189819B (en) A kind of Chinese medicine preparation for being used to nurse one's health emotional health
CN101653504A (en) Traditional Chinese medicine for treating depression
CN103405719A (en) Medicament for treatment of depression
CN104225450A (en) Traditional Chinese medicine for treating depression
CN110314218A (en) A kind of coptis Wendan Tang and preparation method thereof
CN104000987A (en) Traditional Chinese medicine composition for treating postnatal depression
CN103638376B (en) A kind of Chinese medicine tablet for the treatment of rosacea
CN104705634A (en) Lucid ganoderma healthcare product for protecting health
CN104740079A (en) Phyllanthus emblica health-care traditional Chinese medicine composition
CN104740210B (en) A kind of Chinese medicine and preparation method for the treatment of qi stagnation and blood stasis type craniocerebral trauma syndrome
CN102949656A (en) Health care product capsule used for preventing and treating depression and preparation method thereof
CN103638375B (en) A kind of Chinese medicinal granule for the treatment of rosacea
CN103479880B (en) Chinese herbal composition for treating neurasthenia
CN106421422A (en) Traditional Chinese medicine composition for curing insomnia
CN105709013A (en) Application of six-ingredient rehmannia capsules in medicine for treating coronary heart disease and stenocardia
CN103638378B (en) A kind of Chinese medicinal capsule for the treatment of rosacea
CN104940790A (en) Traditional Chinese medicine for treating psychoneurosis
CN1318049C (en) Medicine for treating psoriasis
CN103638377A (en) Traditional Chinese medicine pill for treating rosacea
CN103860827B (en) One treats migrainous Chinese medicine preparation
CN108030866A (en) One kind insomnia Chinese medicine
CN105878866A (en) Traditional Chinese medicinal composition for treating insomnia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190905

Address after: 230000 Woye Garden Commercial Building B-2705, 81 Ganquan Road, Shushan District, Hefei City, Anhui Province

Patentee after: Hefei Long Zhi Yun Pharmaceutical Technology Co., Ltd.

Address before: 251500 Linyi County People's Hospital of Shandong province intravenous drug allocation section

Patentee before: Cao Jing

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20191113

Address after: 363200, Zhangzhou, Fujian province Zhangpu Sui An Industrial Zone

Patentee after: Tongyitang Pharmaceutical Co., Ltd.

Address before: 230000 Woye Garden Commercial Building B-2705, 81 Ganquan Road, Shushan District, Hefei City, Anhui Province

Patentee before: Hefei Long Zhi Yun Pharmaceutical Technology Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220507

Address after: 410000 No. 17, Jinzhou Avenue, high tech Zone, Changsha, Hunan

Patentee after: HUNAN DEKANG PHARMACEUTICAL Co.,Ltd.

Address before: 363200 Suian Industrial Zone, Zhangpu County, Zhangzhou City, Fujian Province

Patentee before: TONGYITANG PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right